After priming, naïve CD8 + T lymphocytes establish specific heritable transcription programs that define progression to long-lasting memory cells or to short-lived effector cells. Although lineage specification is critical for protection, it remains unclear how chromatin dynamics contributes to the control of gene expression programs. We explored the role of gene silencing by the histone methyltransferase Suv39h1. In murine CD8 + T cells activated after Listeria monocytogenes infection, Suv39h1-dependent trimethylation of histone H3 lysine 9 controls the expression of a set of stem cell-related memory genes. Single-cell RNA sequencing revealed a defect in silencing of stem/memory genes selectively in Suv39h1-defective T cell effectors. As a result, Suv39h1-defective CD8 + T cells show sustained survival and increased long-term memory reprogramming capacity. Thus, Suv39h1 plays a critical role in marking chromatin to silence stem/memory genes during CD8 + T effector terminal differentiation.
repressive mark, a hallmark of both constitutive and facultative heterochromatin (12) , most often associated with silent gene loci. Mouse Suv39h1 and Suv39h2, two H3K9 site-specific histone methyltransferases (HMTs), are critical heterochromatin regulators (10, 13) . Suv39h1 is involved in heterochromatin organization, gene silencing, and lineage stability (10, 11, 14) . It also limits somatic reprogramming of differentiated cells into induced pluripotent stem cells (15) . In B cells and CD4 + T cells, Suv39h1 is involved in gene silencing and lineage plasticity (16, 17) . Although the mechanisms underlying the induction of genes critically involved in effector and memory T cell generation have been extensively analyzed, the impact of heterochromatin-dependent gene expression silencing on the fates of T lymphocytes during differentiation has not been addressed. Here, we explore the role of Suv39h1-dependent gene silencing in the establishment and maintenance of memory CD8 + T cell stemness, plasticity, and transition to terminally differentiated effectors.
Long-term protection against Listeria monocytogenes infection requires Suv39h1
To investigate the role of Suv39h1 in T cell responses to infectious agents, we infected Suv39h1-knockout (KO) and wild-type littermate mice with OVA-expressing L. monocytogenes (LM-OVA) (Fig.  1A) . The bacterial burden in the spleen and liver was measured on day 3 (peak of infection in the spleen) and day 7 (resolution). After primary infection, we observed similar bacteremia in the spleen and liver of Suv39h1-KO and littermate control mice, both at the peak and after the resolution of infection (Fig. 1B) . In contrast, upon a secondary challenge with LM-OVA 48 days after the primary infection, most littermate control mice showed complete protection, whereas high levels of LM-OVA were detected in the liver and/ or spleen in more than 85% of Suv39h1-KO mice (Fig. 1C) . Because protection against secondary L. monocytogenes infection is primarily mediated by CD8 + T cells (18) , these results suggested a defect in the CD8 + T cell response against L. monocytogenes in Suv39h1-KO mice.
To further investigate the role of Suv39h1 in antigen-specific CD8 + T cell responses to LM-OVA, we measured the antigen-specific CD8 + T cell response using SIINFEKL (Ser- T cell numbers in LM-OVA-infected Suv39h1-KO mice was T cell-intrinsic, we adoptively transferred Suv39h1-proficient or -deficient T cell receptor transgenic OT-I CD8 + T cells (which recognize OVA) to wild-type mice. Five days after infection with LM-OVA, the numbers of Suv39h1-KO OT-I cells were reduced relative to wild-type OT-I (Fig.  1I ). Although the percentage of IFN-g + OT-I cells was similar, we observed a lower frequency of granzyme B + T cells ( fig. S3 , A to C), confirming that the defect observed in Suv39h1-KO mice was intrinsic to CD8 + T cells. In line with these in vivo results, lower numbers of Suv39h1-KO effector OT-I CD8 + T cells were recovered in vitro under effector-polarizing conditions, relative to numbers of Suv39h1-proficient T cells. Notably, the defective expansion in Suv39h1-KO T cells was overcome by the overexpression of SUV39H1 by a retroviral expression vector ( fig. S4, A and  B) . Thus, CD8 + T cell responses to LM-OVA are impaired in Suv39h1-KO mice because of a CD8 + T cell-intrinsic defect.
Transcriptional silencing by Suv39h1
To investigate whether the reduced K b -OVA + CD8
+ T cell response results from defective gene expression programming, we analyzed RNA profiles by Affymetrix microarrays of purified naïve and K b -OVA + CD8 + T cells, which were wild-type or Suv39h1-KO and isolated by fluorescence-activated cell sorting (FACS) 7 days after LM-OVA infection ( Fig. 2A and fig. S5A ). The overall number of transcripts up-regulated in K b -OVA + CD8 + T cells from infected mice, as compared to naïve CD8 + T cells, was highly similar between littermates (1571) and Suv39h1-KO (1433) T cells (Fig. 2, B and C). In contrast, the number of transcripts from day 7 LM-OVA infected mice were analyzed by mChIP-qPCR using antibodies to H3K9ac. Data are means ± SEM of at least three independent experiments. *P < 0.05, **P < 0.01; for (E) and (F), analysis of variance, Tukey test.
to be commonly enriched both in memory CD8 + T cells and long-term hematopoietic stem cells (21) , overexpressed in mouse and human CD8 + T stem cell-like memory subset (22) and also retrieved from signaling pathways that regulate stem cell pluripotency from the KEGG database. We designated this as a "stem cell-like memory" signature (composed of 86 genes; table S1). K b -OVA + CD8 + T cells from LM-OVA-infected Suv39h1-KO mice were strongly enriched for this signature (Fig. 2F and fig. S5 , B and C). The expression levels of stem cell-like and memory markers Il7r, Ly6a (Ly6a/e, Sca-1), Fas (CD95), and Pou6f1 were all increased in Suv39h1-KO K 
and (iv) CD127
-KLRG1 -double-negative cells (Fig. 2G , left), as described previously (5, 19) . The RNA expression profile of these four FACS-sorted populations was analyzed using Affymetrix microarrays. We tested each of the four subsets (test class) against a combination of the three other FACS-sorted subpopulations, using high-throughput GSEA for the CD8 + T naïve, memory, effector, and stem cell-like/memory signatures (Fig. 2G , lower right). As expected, sorted memory precursors were enriched for both memory and naïve signatures, whereas sorted effectors were enriched for the effector signature (Fig. 2G, right) . Notably, only sorted memory precursors from wild-type mice were enriched for the CD8 + T stem cell-like signature when compared to the three other sorted subpopulations (Fig. 2G, lower right) . Thus, the stem cell-like memory signature, which is specific to memory precursors in wild-type T cells, is broadly enriched in bulk K
H3K9me3 deposition at stem/memory-associated loci
To elucidate the epigenetic states (11) associated with the stem/memory and effector (19, 21) gene loci (tables S1 and S2), we first analyzed a set of public chromatin immunoprecipitation sequencing (ChIP-seq) data sets, generated with naïve, memory precursor, and effector OT-I CD8 + T cells isolated 8 days after LM-OVA infection in vivo (24) . We identified the regions significantly enriched for monomethylated histone H3 Lys 4 (H3K4me1), trimethylated histone H3 Lys 4 (H3K4me3), acetylated histone H3 Lys 27 (H3K27ac), and trimethylated histone H3 Lys 27 (H3K27me3) histone marks. For each histone mark, the significantly enriched islands were associated with the nearest gene (25) . Differences in histone mark relative enrichment were calculated by pairwise comparison of terminal effectors to naïve cells (Fig. 3A, top) or to memory precursors (Fig. 3A, bottom) . The regions associated with the stem cell-like memory genes showed an enrichment in H3K4me1 and H3K4me3 in both naïve cells and memory precursors, as compared to terminal effectors. The enrichment in these active marks, H3K4me1 and H3K4me3, corresponds to the transcription level of the stem cell-like memory genes in both wild-type naïve and memory precursors, as compared to effectors ( fig. S5B ). In contrast, the profile of H3K27ac deposition, typically distal, was more difficult to associate with target genes, including certain stem/memory genes and most effector signature genes in effectors (Fig. 3A) ; of note, cell cycle genes were excluded from this signature (table S2 ). In line with these results, H3K4me1 and H3K27ac marked the effector genes mostly in the effector subset (Fig. 3A) . The enrichment of the repressive mark H3K27me3 on stem cell-like memory genes corresponded with the silencing of the gene signature in the effector CD8 + T cells (Fig. 3A and fig. S5B ). Thus, posttranslational chromatin modifications corresponding to transcriptionally active and repressive marks follow the stem cell-like memory and effector gene expression patterns defined in memory precursors and effector T cell populations, respectively.
To investigate the contribution of Suv39h1-dependent chromatin changes, we performed ChIP-seq for the repressive mark H3K9me3 in naïve and in vitro differentiated effector CD8 + T cells from wild-type and Suv39h1-KO mice ( fig.  S6A ). The total numbers of H3K9me3 islands and targeted genes were higher in wild-type effectors than in wild-type naïve CD8 + T cells (Fig.  3B and fig. S6B ). Most de novo H3K9me3 islands (present in effector but not in naïve T cells) were distal to the transcription start site (TSS), with equal proportions of intra-and intergenic locations (Fig. 3B, top) , and with highest enrichment between 10 and 100 kb from the TSS (fig. S6C) . Thus, H3K9me3 is broadly distributed in both wild-type naïve and effector CD8 + T cells, and the number of H3K9me3 islands increases in effector CD8 + T cells relative to naïve CD8 + T cells. Among the 997 genes that are less efficiently silenced in vivo in Suv39h1-KO cells relative to littermates (Fig. 2C) , 145 genes were decorated by H3K9me3 ( fig. S6C) . Several of these genes encode immune and stem/memory-related proteins, including CD127 or CD62L (Fig. 3C) . In effectors, the Il7r gene acquires H3K9me3 at sites both proximal and distal to the TSS, including the promoter, previously described enhancers, introns, and intergenic regions (Fig. 3C, upper left) (26) . H3K9me3 deposition is also increased at the Sell locus, upstream the promoter region, in effectors as compared to naïve CD8 + T cells (Fig. 3C, lower  left) . No significantly enriched H3K9me3 islands were found for actively transcribed housekeeping and control genes (Fig. 3C, right) . These results suggest that H3K9me3 silences genes linked to naïve versus effector differentiation, including Il7r and Sell.
To (Fig. 3D) . (Fig. 3E and fig. S6D ), whereas in effector T cells, the levels of H3K9me3 were increased at both loci, again in correlation with gene silencing (Fig. 3E) . Consistent with the expression results, central memory cells, like naïve cells, have low levels of H3K9me3 at both promoters, whereas the reduced expression of Il7r and Sell in effector cells correlated with H3K9me3 enrichment.
Suv39h1-KO effector CD8 + T cells did not show a significant increase of H3K9me3 at the Il7r or Sell loci, consistent with impaired silencing of Il7r and Sell expression (Figs. 2D and 3E) . Likewise, CD8
+ central memory T cells and naïve cells presented low levels of H3K9me3 at both the Sell and Il7r promoters (Fig. 3E ). Also consistent with these results, the level of the alternative active mark H3K9ac is increased in effectors at both Il7r and Sell loci in Suv39h1-KO CD8 + T cells alone, which was again consistent with gene expression profiles (Fig. 3F) (Fig. 4A) . The increased proportion of CD127 + cells was due to decreased numbers of CD127 lo/-KLRG1 + effector T cells (Fig. 4, A  and B, right) . The absolute numbers of CD127 lo cells (both KLRG1 + and KLRG1 -) were reduced, whereas the number of CD127 high memory precursor cells was unchanged (Fig. 4, A and B,  left) . In Suv39h1-KO mice, K b -OVA + CD8 + T cells also included a lower proportion of CD27 lo cells and impaired down-regulation of CD62L in a subpopulation of cells ( fig. S7, A and B) . Enhanced memory differentiation of wild-type/ Suv39h1-KO 1:1 mixed bone marrow chimeras upon LM-OVA infection resulted in a significantly higher proportion of effectors among wild-type cells, whereas the proportion of memory precursors was increased among Suv39h1-KO K b -OVA + T cells (Fig. 4C and fig. S8 ). Similar results were obtained after the adoptive transfer of wild-type and Suv39h1-KO OT-I CD8 + T cells ( fig. S3, D and E) . Thus, Suv39h1-KO mice develop increased proportions of memory T cells in response to L. monocytogenes infection as the result of a T cell-intrinsic defect in effector differentiation.
We next sought to determine the impact of the Suv39h1 defect on long-term memory versus effector differentiation and persistence. The numbers of K b -OVA + CD8 + T memory cells and effectors were analyzed 7, 18, and 47 days after LM-OVA infection, and 3 days after rechallenge on day 51. As expected from previous results (Fig.  4B) , the number of effectors was reduced at all times, including at the peak of the rechallenge memory response in the blood (Fig. 4D) and  spleen (fig. S9, right) . The numbers of memory cells did not change between wild-type and Suv39h1-KO at the peak of the response, during contraction, or after rechallenge (Fig. 4E and fig.  S9, left) (27) increased over time in Suv39h1-KO mice as compared to wild-type mice (Fig. 4F) . Notably, the percentage of endogenous subsets of memory CD8 + T cells in Suv39h1-KO mice was also higher, including polyclonal CD62L + central memory CD8 + T cells in the blood and secondary lymphoid organs (Fig. 4, G and H, and fig. S10 , A to C), CD62L
-effector memory CD8 + T cells in the bone marrow and blood ( fig. S10D) An analysis of master regulators involved in memory and effector differentiation showed that the proportion of LM-OVA-specific T cells expressing T-bet is reduced in both IFN-g + and IFN-g -Suv39h1-KO cells as compared to littermates ( Fig. 4I and fig. S11 ). Similarly, the expression of Eomes, Blimp1, and Bcl6 was also reduced ( fig. S11) . Thus, Suv39h1-KO CD8 + T cells display a central memory-like phenotype but express reduced levels of both effector and memory transcription master regulators (4, 5) .
Previous adoptive transfer experiments showed that only CD127 + memory precursors give rise to long-term memory cells and confer protective immunity (29) . To evaluate their in vivo memory self-renewal and differentiation properties, we isolated wild-type and Suv39h1-KO CD45.2 K b -OVA + CD8 + T cells 7 days after LM-OVA infection and adoptively transferred them at low numbers into naïve congenic CD45.1 recipients (Fig. 5A  and fig. S12A ). Forty days after challenge with LM-OVA, as expected, few wild-type K b -OVA + T cells persisted or responded to the LM-OVA challenge. In contrast, donor Suv39h1-KO CD45.2 K b -OVA + T cells were clearly present and responded to the infection (Fig. 5, B and C) , with an increased proportion of memory precursor and effector cells (Fig. 5, B and D (Fig. 5A and  fig. S12A ). Thirty-nine days after adoptive transfer, similar numbers of wild-type and Suv39h1-KO donor CD8 + T cells, which had maintained a central memory phenotype, were present in the blood (Fig. 5G, left, and fig. S12B ). Four days after LM-OVA rechallenge, however, both the percentage and the total numbers of Suv39h1-KO donor CD8 + T cells were increased relative to control Suv39h1-sufficient cells (Fig. 5, E and G, right) . Donor Suv39h1-KO CD8 + T cells displayed higher expression of both CD127 and CD62L, lower levels of KLRG1 and CD44, a slight decrease in the expression of SCA-1, and similar levels of CD122 (Fig. 5, E and F) . The donor memory subset was increased in the animals adoptively transferred with Suv39h1-KO T cells (Fig. 5H) . Thus, Suv39h1-KO K b -OVA + and central memory CD8 + T cells have superior self-renewal and repopulation potential relative to their wild-type counterparts.
Stemness gene silencing in terminal effectors requires Suv39h1
Increased proportions of T cells with a central memory phenotype and stem cell-like properties were found in Suv39h1-KO mice. This phenotype could be due to the accumulation of a defined population of stem cell-like memory T cells, or to the expression of stem cell-related genes across different T cell subpopulations. We used singlecell RNA sequencing (scRNA-seq) to explore and dissect the heterogeneity of wild-type and 
CD8
+ T cells, we processed two technical replicates for both wild-type and Suv39h1-KO infected mice (approximately 1200 and 1000 cells, respectively) and an additional biological replicate (from different mice, 404 wild-type and 283 Suv39h1-KO K b -OVA + CD8 + T cells). The cells from the two technical replicates were pooled and used for the rest of the analysis. A comparison between technical and biological replicates within wild-type and Suv39h1-KO mice showed a strong correlation (figs. S13 to S15).
A principal components analysis (PCA) of differentially expressed genes by wild-type and Suv39h1-KO naïve and K b -OVA + CD8 + T cells, is visualized as a set of t-distributed stochastic neighbor embedding (t-SNE) plots in Fig. 6A S14, A and B, and tables 3 and 4) . On the basis of distinct transcription profiles, we grouped the unsupervised clusters into four major subset categories: naïve, memory precursor, effector, and cycling cells (Fig. 6, B to D, and fig. S14C ). As expected, the naïve cells grouped in a homogeneous category characterized by the highest expression of Sell, Ccr7, and Tcf7 (Fig. 6B) . The memory precursors were enriched in Il7r, Cxcr3, Cd27, Cd28, and Ly6a expression (Fig. 6, B and  E) ; the effectors were characterized by Zeb2, Klrg1, and granzyme B (Fig. 6, B and E, and fig. S16) ; and the cycling subsets were defined by cell cycle genes including Pcna and Mcm5 (Fig. 6, B (Fig. 6D) . This is likely due to the resolution of the cycling cells, which also express high levels of different effector markers, including KLRG1 and granzyme A and B (Fig. 6, B and E, and fig. S16 ). Consistent with flow cytometric analysis, the proportion of Suv39h1-KO effector K b -OVA + CD8 + T cells was decreased (Fig. 6D and fig. S14 ). Thus, unsupervised scRNA-seq allows resolution of the expected memory precursors and effector populations among K b -OVA + CD8 + T cells. The scRNA-seq analysis also reveals a population expressing high levels of genes involved in the cell cycle, as well as markers of memory precursors and effectors.
Having defined the different populations of antigen-specific CD8 + T cells, we next sought to analyze the expression of stem cell/memory genes in wild-type and Suv39h1-KO cells. As expected, wild-type cells showed enrichment of stem cell markers (i.e., Cxcr6, Rnf138, Il18r1, and Traf1) in the memory precursors (Fig. 6F) . In Suv39h1-KO T cells, the expression of these markers was also high in memory precursors, but, in contrast to wild-type cells, expression was also detected in effector and cycling populations. Similar increased expression of the stem/memory signature in Suv39h1-KO effectors could be visualized on t-SNE plots where the number of genes from the stem/memory signature per cell is represented by a color scale (Fig. 6G) . These results suggest that Suv39h1-defective effectors express higher levels of certain stem/memory-related genes, consistent with impaired silencing.
To further analyze the expression of the stem cell-like memory and effector signature genes at the single-cell level among the different populations, we used density scatterplots in which the numbers of genes from each signature are represented against each other (Fig. 6H) . In most naïve cells from both wild-type and Suv39h1-KO mice, we detected an average of seven stem/ memory signature genes per cell, and fewer than four genes from the effector signature. As expected, in the wild type, memory precursors, relative to naïve cells, expressed higher numbers of genes from the stem/memory signature (mean of 9 genes per cell; 43% with more than 10 genes per cell) as well as high numbers of genes from the effector signature (mean of 18 genes per cell). The proportion of effector cells expressing high numbers (>10 per cell) of stem/memory genes was reduced (16%) as compared with memory cells (43%), whereas there was only a modest increase in the number of genes from the effector signature (mean 20 genes). Of note, the gene expression levels from the effector signature were strongly increased in effectors as compared to memory cells (Fig. 6B and fig. S16 ). Notably, cycling cells coexpressed either low or high numbers of r=0.68 p<10 -13 r=0.47 p<10 -13 r=0.43 p<10 -13 genes from both signatures. Thus, scRNA-seq analysis reveals the alternative expression of the stem/memory and effector signatures in the two cell types, respectively, and the concomitant low or high expression of these two signatures in the cycling cells. These results suggest that cycling cells may represent bipotent differentiation intermediates expressing both effector and stem/memory potential. Furthermore, the commitment to effector differentiation paths appears to be acquired by the silencing of stem/memory genes. The total number of unique molecular identifiers (UMI) measured in each subset category did not differ between wild-type and Suv39h1-KO cells ( fig. S17, A and B) . Naïve, cycling, and memory Suv39h1-KO cells bear similar patterns of gene expression signatures as compared to wild-type cells. In contrast, a significant difference was observed in effector cells, in which the numbers of stem/ memory genes per cell were increased relative to effector cells from wild-type mice. The proportion of cells expressing more than 10 genes from the stem/memory signature was augmented from 16% in the wild type to 34% in effector Suv39h1-KO cells. Thus, rather than a specific subpopulation of stem/memory cells accumulating in the Suv39h1-KO mice, the expression of stem/memory-related genes was derepressed mainly in Suv39h1-KO effector T cells.
Conclusions
We argue that after priming, cycling CD8 + T lymphocytes reprogram both self-renewing and effector gene expression profiles (Fig. 6I) . These cycling cells may represent bipotent intermediates, which would then repress either the effector or stem cell/memory programs while they differentiate to memory precursors or effectors, respectively (Fig. 6I) . The silencing of the stem cell/memory gene expression program is under the control of Suv39h1 by imposing the H3K9me3 modification on chromatin at the corresponding loci. In doing so, Suv39h1/H3K9me3 would establish an epigenetic barrier on the stem/memory gene expression program, preventing effector reprograming into memory cells (Fig. 6I) . It is most likely that the possibly reversible silencing of effector gene expression in memory cells occurs through other mechanisms, as memory cells do effectively reprogram into effectors upon rechallenge. These results open new perspectives for the manipulation of epigenetic programming of T lymphocyte identity in the context of vaccination, checkpoint-based immunotherapies, and adoptive T cell therapies.
